Life Sciences

Pfizer Bextra settlement could top $2B

Pharma Compliance Alert, February 4, 2009

A $2.3 billion estimated settlement could eclipse Eli Lilly?s $1.4 billion payment to resolve allegations of off-label promotion.

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below:

   
   

Most Popular